PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Takeda and the Digital Healthcare Evolution

Can FDA Control Drug Prices?

2016 Emerging Pharma Leaders — Nominate Now
Advertisement
Top Feature
How Did Things Get This Bad? Look in the Mirror, US Pharma
As US pharma continues to ponder its “winter of discontent” and ask, “How did things get this bad?”, the industry might want to take a long look in the mirror, writes Tom Norton
... /Read more/
 
Transparency
Rooting Out Pharma Corruption
Transparency International (TI), an anti-corruption organization currently best known for its Corruption Perceptions Index, now has pharma in its sights. Pharm Exec speaks to TI about how it will go about understanding and combating corruption in the sector
... /Read more/
 
Advertisement
The ZS Explorer Study finds that pharma investments in sales force effectiveness boost revenue 1 - 7%. That might not sound like much, but given their size and scale, pharmacos can achieve a substantial return on sales force effectiveness investments.
Read the report to see the latest data on pharma sales force effectiveness.
 
Regulatory
New Strategies Needed to Clarify Off-Label Marketing
Various factors have altered the landscape for exchange of information on drugs and medical products, but the FDA has not kept pace in updating its rules governing what marketers can say about their therapies, writes Jill Wechsler.
... /Read more/
Emerging Pharma Leaders
Pharm Exec's Emerging Pharma Leaders 2016 — Nominate Now
Pharm Exec is looking for the fresh faces of pharma leadership. And we'd like your input. Tell us who you think should be included as one of our 2016 Emerging Pharma Leaders. These leaders are vital to the future of the industry, and you can help ensure they get the recognition they deserve. Fill out your nomination today
... /Read more/
 
Advertisement
SPEED TO INSIGHT: 4 Strategies you need to maximize the value of your data assets
ON DEMAND
Join Hewlett Packard Enterprise and Linguamatics as they discuss the right questions to ask about your company's analytics capabilities to gain a competitive advantage.
Learn more
 
Europe
A Vicious Circle: The EU Drug Pricing System
A new study spells out the many drug pricing problems in Europe just fine, but fails to address a central access issue—leaving its recommendations frustratingly limited for industry and policymakers
... /Read more/
 
Calendar
/ March 15–17: eyeforpharma 2016 /
Barcelona, Spain
/ March 22–23: 9th Annual Oncology Commercialization and Market Access /
San Francisco, CA.
/ April 18–19: IRT Europe — Interactive Response Technologies in Clinical Trials /
Brussels, Belgium
/ June 21–22: Patient Engagement Solutions Summit /
Philadelphia, PA.
/ August 15–17: 10th Annual Forum on Transparency and Aggregate Spend /
Washington, DC.
 
Industry update
//Catalyst Pharmaceuticals, Inc. (Coral Gables, FL) announced the appointment of Brian Elsbernd as Senior Vice President of Legal and Compliance.//Tonix Pharmaceuticals Holding Corp. (New York, NY) appointed Bradley Saenger, CPA, as Chief Financial Officer. The company also appointed Jessica Morris, who was serving as Acting CFO, to Executive Vice President of Administration.//Sagent Pharmaceuticals, Inc. (Schaumburg, IL) named Frank Harmon as Executive Vice President, Global Operations.//Agile Therapeutics, Inc. (Princeton, NJ) appointed Ajit S. Shetty, Ph.D., to its Board of Directors.//MannKind Corporation (Valencia, CA) reported the passing of its Chairman Emeritus, Alfred E. Mann, aged 90.//
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com